{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:59:54Z","timestamp":1780891194529,"version":"3.54.1"},"reference-count":34,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The optimal oocyte yield in gonadotropin-releasing hormone (GnRH) antagonist in vitro fertilization (IVF) cycles remains debated, and data specific to antagonist protocols are limited. This study evaluated the discriminative and independent predictive performance of oocyte count for clinical pregnancy in GnRH antagonist IVF cycles. Materials and Methods: This retrospective cohort included 1171 women undergoing their first GnRH antagonist IVF cycle with fresh embryo transfer at a single tertiary center (September 2007\u2013December 2021). The primary outcome was an institutional composite pregnancy outcome (sustained \u03b2-hCG positivity with subsequent ongoing intrauterine pregnancy or live birth; biochemical and ectopic pregnancies were negative). Patients were grouped by oocytes retrieved (1\u20135, 6\u201310, 11\u201315, \u226516). Performance was assessed with logistic regression, ROC with 2000-iteration bootstrap, integrated discrimination improvement (IDI), continuous net reclassification improvement (NRI), and restricted cubic spline. Predefined subgroup analyses by age, regimen, and antral follicle count tertile were performed. Results: A positive outcome occurred in 430 patients (36.7%). After adjustment, oocyte count was not an independent predictor (adjusted odds ratio 0.999, 95% CI 0.979\u20131.020; p = 0.96). The full model (AUC 0.564, 95% CI 0.529\u20130.598) did not outperform oocyte count alone (AUC 0.532; bootstrap p = 0.11). IDI (0.011) and NRI (0.135) were statistically detectable but clinically trivial. Spline regression showed no non-linearity (p = 0.47). Findings were consistent across subgroups, and the narrow confidence interval excluded per-oocyte effects \u22651.10. Conclusions: In GnRH antagonist IVF cycles, oocyte count showed weak discriminatory performance and was not independently associated with fresh-cycle pregnancy. Oocyte yield should be interpreted alongside\u2014rather than as a substitute for\u2014established parameters such as age and ovarian reserve. The principal clinical value of a higher oocyte response may lie in cumulative rather than fresh-cycle success. Live-birth outcomes were not available, and the source institution was permanently closed in 2025; these limitations define the boundary of inference.<\/jats:p>","DOI":"10.3390\/medicina62061110","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T02:32:46Z","timestamp":1780885966000},"page":"1110","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive Performance of Oocyte Count for Clinical Pregnancy in GnRH Antagonist IVF Cycles: A Multivariable Analysis of 1171 Fresh Embryo Transfers over a 14-Year Period"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-6767","authenticated-orcid":false,"given":"\u00d6mer Osman","family":"Ero\u011flu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ankara Etlik Z\u00fcbeyde Han\u0131m Women\u2019s Health Training and Research Hospital, Ankara 06010, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-8702","authenticated-orcid":false,"given":"Runa","family":"\u00d6zel\u00e7i","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ankara Etlik Z\u00fcbeyde Han\u0131m Women\u2019s Health Training and Research Hospital, Ankara 06010, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-4246","authenticated-orcid":false,"given":"Ramazan Erda","family":"Pay","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ankara Etlik Z\u00fcbeyde Han\u0131m Women\u2019s Health Training and Research Hospital, Ankara 06010, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cans\u0131n","family":"Ero\u011flu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ankara Etlik Z\u00fcbeyde Han\u0131m Women\u2019s Health Training and Research Hospital, Ankara 06010, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mascarenhas, M.N., Flaxman, S.R., Boerma, T., Vanderpoel, S., and Stevens, G.A. (2012). National, regional, and global trends in infertility prevalence since 1990: A systematic analysis of 277 health surveys. PLoS Med., 9.","DOI":"10.1371\/journal.pmed.1001356"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/humrep\/dey242","article-title":"ART in Europe, 2014: Results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","volume":"33","author":"Kupka","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_3","unstructured":"European IVF Monitoring Consortium (EIM), for the European Society of Human Reproduction and Embryology (ESHRE), Wyns, C., De Geyter, C., Calhaz-Jorge, C., Kupka, M.S., Motrenko, T., Smeenk, J., Bergh, C., Tandler-Schneider, A., and Goossens, V. (2022). ART in Europe, 2018: Results generated from European registries by ESHRE. Hum. Reprod. Open, 2022, hoac022."},{"key":"ref_4","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"2016","author":"Youssef","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/humupd\/dml001","article-title":"GnRH antagonists in ovarian stimulation for IVF","volume":"12","author":"Tarlatzis","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: Ovarian stimulation for IVF\/ICSI","volume":"2020","author":"Stimulation","year":"2020","journal-title":"Hum. Reprod. Open"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: An analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum. Reprod."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/humrep\/det303","article-title":"The optimum number of oocytes in IVF treatment: An analysis of 2455 cycles in China","volume":"28","author":"Ji","year":"2013","journal-title":"Hum. Reprod."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1472-6483(10)60633-5","article-title":"Optimum number of oocytes for a successful first IVF treatment cycle","volume":"13","author":"Eijkemans","year":"2006","journal-title":"Reprod. Biomed. Online"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.fertnstert.2006.02.086","article-title":"Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization\u2013embryo transfer","volume":"86","author":"Mitwally","year":"2006","journal-title":"Fertil. Steril."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.fertnstert.2009.02.066","article-title":"Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner","volume":"93","author":"Joo","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: A randomized controlled trial","volume":"22","author":"Baart","year":"2007","journal-title":"Hum. Reprod."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2633494120941480","DOI":"10.1177\/2633494120941480","article-title":"Update on the management of poor ovarian response in IVF: The shift from Bologna criteria to the Poseidon concept","volume":"14","author":"Drakopoulos","year":"2020","journal-title":"Ther. Adv. Reprod. Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12958-024-01291-x","article-title":"Patients with low prognosis in ART: A Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria","volume":"22","author":"Alviggi","year":"2024","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yan, E., Li, W., Jin, H., Zhao, M., Chen, D., Hu, X., Chu, Y., Guo, Y., and Jin, L. (2023). Cumulative live birth rates and birth outcomes after IVF\/ICSI treatment cycles in young POSEIDON patients: A real-world study. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1107406"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/humupd\/dmq015","article-title":"Predictive factors in in vitro fertilization (IVF): A systematic review and meta-analysis","volume":"16","author":"Limpens","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: An analysis of 256,381 in vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"Altman","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_19","first-page":"CD003719","article-title":"Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles","volume":"23","author":"Youssef","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Harrell, F.E. (2015). Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis, Springer. [2nd ed.].","DOI":"10.1007\/978-3-319-19425-7"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.rbmo.2021.02.010","article-title":"Oocyte or embryo number needed to optimize live birth and cumulative live birth rates in mild stimulation IVF cycles","volume":"43","author":"Datta","year":"2021","journal-title":"Reprod. Biomed. Online"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/humrep\/dex334","article-title":"The number of oocytes retrieved during IVF: A balance between efficacy and safety","volume":"33","author":"Magnusson","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10815-005-4875-9","article-title":"The relationship of clinical response, oocyte number, and success in oocyte donor cycles","volume":"22","author":"Letterie","year":"2005","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00404-014-3332-3","article-title":"Predictive value of anti-m\u00fcllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF\/ET","volume":"290","author":"Tsakos","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Lian, F., Xiang, S., Yu, Y., Pang, C., and Qiu, Y. (2021). Effects of half-dose and full-dose GnRH antagonists on IVF-ET outcomes: A retrospective study. BMC Pregnancy Childbirth, 21.","DOI":"10.1186\/s12884-021-04176-8"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/humrep\/deae145","article-title":"A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: A randomized controlled trial","volume":"39","author":"Xu","year":"2024","journal-title":"Hum. Reprod."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-019-0460-4","article-title":"The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: A systematic review and meta-analysis","volume":"17","author":"Conforti","year":"2019","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.fertnstert.2012.05.042","article-title":"Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women","volume":"98","author":"Jayaprakasan","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: Comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: A multicenter multinational analysis including ~15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fertnstert.2016.10.037","article-title":"How many oocytes are optimal to achieve multiple live births with one stimulation cycle? The one-and-done approach","volume":"107","author":"Vaughan","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(05)66478-1","article-title":"Multiple birth resulting from ovarian stimulation for subfertility treatment","volume":"365","author":"Fauser","year":"2005","journal-title":"Lancet"},{"key":"ref_34","first-page":"CD002118","article-title":"Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology","volume":"5","author":"Glujovsky","year":"2022","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1110\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T03:47:54Z","timestamp":1780890474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medicina62061110"],"URL":"https:\/\/doi.org\/10.3390\/medicina62061110","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]}}}